Searched for
ARV
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Delhi toddler turned away from hospital after stray dog bite as anti-rabies vaccine unavailable despite SC ordersJust days after a Supreme Court order for prompt dog-bite treatment, a Delhi girl was turned away from a hospital due to vaccine unavailabi...
- Laurus Labs shares nosedive 15% amid reports of US foreign aid suspensionLaurus Labs reported a 7% YoY drop in API revenues to Rs 531 crore for Q3 FY24, driven by lower ARV volumes. However, the FDF segment saw A...
- No weight loss, Arvind Kejriwal gained 1 kg in Tihar jail: BJP's Ramvir Singh Bidhuri cites official medical health chartDelhi's LoP Ramvir Singh Bidhuri contested claims of Delhi CM Arvind Kejriwal losing weight in Tihar Jail, citing official health records i...
- Army to procure 170 armoured recovery vehiclesThe Indian Army has begun the process of procuring 170 Armoured Recovery Vehicles (ARVs) to enhance its operational capabilities. The ARVs ...
- Prices can’t go down further in APIs or it will turn unviable for new entrants: Laurus Labs CEO“If you look at the current nine months financials, the ARV APIs and formulation put together contributed only 35% of revenue came from ARV...
- Adequate stock of antiretroviral drugs for 95% 'People Living with HIV' in India: SourcesThere is no reported stock out for any antiretroviral (ARV) drugs at the state level and fresh supply orders for procurement of the next lo...
- Pharma companies set to supply ARVs for ‘treatment’Though there is no formal cure discovered to treat the virus, the treatment protocol established in China and confirmation by physicians in...
- Mylan gets approval to launch HIV drug in India, says it will be priced “lower” than othersAround 21 lakh people are estimated to be living with HIV in India but only 14 lakh are known cases, according to the health ministry.
- India calls for flexibilities in IPR to combat AIDSJP Nadda said India will need to "front load" its investments substantially to almost double the number of people on ARV treatment in less ...
- India not promoting Tenofovir, an HIV treatment drug that can also prevent the diseaseThe recommendation opens up a new debate on the use of ARVs as a preventive drug and how it will be perceived among those who engage in uns...
- Flaws in contract terms stall $275-mn ARV dealThe $275 million armoured recovery vehicle deal has run into fresh trouble relating to specification mismatch that has been red-flagged by ...
- Now, CBI to probe BEML’s ARV deal with ArmyAfter Tatra trucks, the Central Bureau of Investigation (CBI) is focusing on the procurement of armoured recovery vehicles (ARV) WZT-3 to t...
- Ranbaxy arm bags Rs 605 cr anti-HIV drug order in South AfricaThe 913.5 million rand order bagged by Sonke is a part of a 4.28 billion rand national anti-retroviral tender floated by the South African ...
- Indian firm sues South Africa after losing AIDS drug contractAn Indian manufacturer of drugs to treat HIV/AIDS is suing the South African government after failing to clinch a $400-million tender, Sout...
- J&J gets patent for ARV drug EtravirineUS major Johnson and Johnson (J&J) has been granted a patent for its anti retroviral drug (ARV) Etravirine in India-the second anti-ARV dru...
- Ranbaxy gets USFDA nod to market two ARV drugsRanbaxy Laboratories has received US Food and Drug Administration’s (USFDA) approval to manufacture and market two paediatric anti-retrovir...
- Ranbaxy gets approval to produce, sell anti-AIDS drugCountry's largest drug maker, Ranbaxy Laboratories Limited (RLL) on Monday said it had received approval to manufacture and market anti-AID...
Load More
